Punch & Associates Investment Management, Inc. Bristol Myers Squibb CO Transaction History

Punch & Associates Investment Management, Inc.

$1.62 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$48.48 - $57.85 $205,894 - $245,688	4,247 New	4,247 $217,000
Q3 2023 Oct 26, 2023	BUY	$57.89 - $64.73 $60,610 - $67,772	1,047 Added 32.72%	4,247 $246,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $4,066 - $4,478	-56 Reduced 1.72%	3,200 $246,000
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $3,442 - $4,128	56 Added 1.75%	3,256 $238,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $171,616 - $200,064	3,200 New	3,200 $200,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $189,344 - $221,792	-3,200 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$59.34 - $66.74 $189,888 - $213,567	3,200 New	3,200 $202,000

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.93 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.87 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Account